The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 762 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 26.12
Cancer of the Thyroid (Invasive)
Race/ Ethnicity |
Current Age | Risk of Being Diagnosed with Cancer | Risk of Dying from Cancer | |||
---|---|---|---|---|---|---|
+10 yrs | +20 yrs | +30 yrs | Eventually | Eventually | ||
All Races | 0 | 0.00 | 0.02 | 0.10 | 1.15 | 0.06 |
10 | 0.02 | 0.10 | 0.26 | 1.17 | 0.06 | |
20 | 0.08 | 0.24 | 0.46 | 1.15 | 0.06 | |
30 | 0.17 | 0.38 | 0.61 | 1.08 | 0.06 | |
40 | 0.22 | 0.45 | 0.67 | 0.93 | 0.06 | |
50 | 0.24 | 0.47 | 0.65 | 0.73 | 0.06 | |
60 | 0.24 | 0.43 | 0.51 | 0.52 | 0.06 | |
70 | 0.21 | 0.30 | - | 0.31 | 0.06 | |
80 | 0.11 | - | - | 0.13 | 0.05 | |
White | 0 | 0.00 | 0.02 | 0.11 | 1.21 | 0.06 |
10 | 0.02 | 0.11 | 0.29 | 1.22 | 0.06 | |
20 | 0.09 | 0.26 | 0.49 | 1.21 | 0.06 | |
30 | 0.18 | 0.40 | 0.65 | 1.13 | 0.06 | |
40 | 0.23 | 0.47 | 0.71 | 0.96 | 0.06 | |
50 | 0.25 | 0.49 | 0.67 | 0.75 | 0.06 | |
60 | 0.25 | 0.44 | 0.52 | 0.53 | 0.06 | |
70 | 0.22 | 0.30 | - | 0.32 | 0.06 | |
80 | 0.12 | - | - | 0.13 | 0.05 | |
Black | 0 | 0.00 | 0.01 | 0.03 | 0.66 | 0.05 |
10 | 0.01 | 0.04 | 0.12 | 0.68 | 0.05 | |
20 | 0.03 | 0.11 | 0.24 | 0.67 | 0.05 | |
30 | 0.09 | 0.21 | 0.35 | 0.65 | 0.05 | |
40 | 0.13 | 0.27 | 0.42 | 0.58 | 0.05 | |
50 | 0.15 | 0.31 | 0.42 | 0.47 | 0.05 | |
60 | 0.18 | 0.30 | 0.34 | 0.36 | 0.05 | |
70 | 0.15 | 0.20 | - | 0.21 | 0.05 | |
80 | 0.07 | - | - | 0.10 | 0.04 | |
Asian/ Pacific Islander |
0 | 0.00 | 0.02 | 0.09 | 1.24 | 0.12 |
10 | 0.02 | 0.09 | 0.25 | 1.25 | 0.12 | |
20 | 0.07 | 0.23 | 0.45 | 1.24 | 0.12 | |
30 | 0.17 | 0.38 | 0.61 | 1.17 | 0.12 | |
40 | 0.22 | 0.45 | 0.68 | 1.02 | 0.12 | |
50 | 0.24 | 0.48 | 0.67 | 0.81 | 0.12 | |
60 | 0.25 | 0.45 | 0.55 | 0.59 | 0.12 | |
70 | 0.22 | 0.33 | - | 0.37 | 0.11 | |
80 | 0.13 | - | - | 0.18 | 0.09 | |
American Indian/ Alaska Nativea |
0 | 0.00 | 0.01 | 0.04 | 0.77 | 0.04 |
10 | 0.01 | 0.04 | 0.14 | 0.78 | 0.04 | |
20 | 0.04 | 0.13 | 0.25 | 0.77 | 0.04 | |
30 | 0.09 | 0.22 | 0.34 | 0.75 | 0.04 | |
40 | 0.13 | 0.25 | 0.41 | 0.67 | 0.05 | |
50 | 0.13 | 0.30 | 0.50 | 0.57 | 0.05 | |
60 | 0.18 | 0.40 | 0.46 | 0.46 | 0.05 | |
70 | 0.25 | 0.32 | - | 0.32 | 0.05 | |
80 | 0.10 | - | - | 0.10 | 0.04 | |
Hispanicb | 0 | 0.00 | 0.02 | 0.08 | 1.08 | 0.09 |
10 | 0.02 | 0.08 | 0.21 | 1.09 | 0.09 | |
20 | 0.06 | 0.19 | 0.36 | 1.07 | 0.09 | |
30 | 0.13 | 0.30 | 0.50 | 1.01 | 0.09 | |
40 | 0.17 | 0.38 | 0.59 | 0.90 | 0.09 | |
50 | 0.21 | 0.43 | 0.62 | 0.74 | 0.09 | |
60 | 0.23 | 0.43 | 0.53 | 0.55 | 0.09 | |
70 | 0.22 | 0.33 | - | 0.36 | 0.08 | |
80 | 0.14 | - | - | 0.17 | 0.06 |
Footnotes:
Devcan 6.8.0, August 2014, National Cancer Institute (https://surveillance.cancer.gov/devcan/).
Source: Incidence data are from the SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey, and Georgia excluding ATL/RG). Mortality data are from the NCHS public use data file for the total US.
a Underlying incidence and mortality data for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.
b Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry.
- Statistic could not be calculated.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.